12 Weeks Open Label, Parallel Group, Comparative, Multi Centric Phase III Study to assess Efficacy and Safety of Metered Dose Buccal Insulin Spray versus Rapid Insulin, s.c. on Subjects with Type II Diabetes who are Inadequately Controlled (i.e.6.5%
A Multi Centric Open Labeled Phase IV Study to evaluate the efficacy and safety of a fixed dose combination tablet of Triproline and Phenylepherine in the use of Rhinitis patients.
A Multi Centric Open Labeled Phase IV Study of a fixed dose Composition containing Amylase and Pepsin to evaluate the efficacy and safety on dysfunctional Dyspepsia.